Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Full FDA approval for DepoCyt for lymphomatous meningitis

April 23, 2007

BGC-945 emerges as a tumor-targeted agent with minimal toxicity

April 23, 2007

European orphan drug designation for PDX in peripheral T-cell lymphoma

April 23, 2007

Indevus seeks to return Valstar to U.S. market

April 23, 2007

Novacea gains additional rights to AQ4N

April 23, 2007

Genta plans new phase III study of Genasense in advanced melanoma

April 23, 2007

Nonhematotoxic naphthalimide derivative and prodrug show promising preclinical activity

April 23, 2007

CovX designs Ang2-targeted antibody with promising antitumor activity

April 20, 2007

PF-337210, a new, selective, orally bioavailable VEGFR-2 inhibitor

April 20, 2007

Development of new water-soluble topoisomerase I inhibitor reported by Chugai

April 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...